Rachel Kroe‐Barrett

机构：Boehringer Ingelheim (United States) · ORCID：0000-0003-1413-1223

发表论文 66 篇 · 总被引 1673 次 · h-index 23

代表论文

• Comparison of biosensor platforms in the evaluation of high affinity antibody-antigen binding kinetics (2016 · Analytical Biochemistry · 被引 126)
• Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody (2015 · mAbs · 被引 122)
• IgG Charge: Practical and Biological Implications (2019 · Antibodies · 被引 99)
• Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies (2017 · mAbs · 被引 86)
• DABIGATRAN ANTICOAGULANT ACTIVITY IS NEUTRALIZED BY AN ANTIBODY SELECTIVE TO DABIGATRAN IN IN VITRO AND IN VIVO MODELS (2011 · Journal of the American College of Cardiology · 被引 78)
• Competing aggregation pathways for monoclonal antibodies (2014 · FEBS Letters · 被引 76)